Singapore
Singapore’s public hospitals may struggle to provide sufficient capacity for patients by 2030
Singapore’s public hospitals may struggle to provide sufficient capacity for patients by 2030
Hospital admissions will skyrocket to 791,000 yearly.
Chart of the Week: Asia braces for more spending as chronic diseases increase prevalence
Asia-Pac’s US$1.5b healthcare market will grow by 7.7% in 2020.
Health system bureaucracy among top concern for Asia’s healthcare professionals
Over half believe that it hinders healthcare coordination.
Queen Mary Hospital introduces ex-vivo lung perfusion for patients with severe breathing problems
Dr Luk Che-Chung expects lung transplant cases to double in the coming years.
Singapore's Pioneer Generation to get $190m in Medisave top-ups this year
Top-ups range from $200 to $800.
Sustainability woes threaten Asia’s universal healthcare schemes
Indonesia has accumulated a deficit of US$302m in 2015.
Q&M Dental Group’s third-largest China deal could open larger opportunities, analysts say
It will buy stakes in a dental research firm for SGD13.8m.
Here’s why Raffles Med has no problem securing top medical talent in China
They rely on their group practice model.
Chart of the Week: Check out how healthcare spending is expected to boom
It’s expected to rise by 7.7% by 2020.
Can IHH Healthcare withstand rising cost pressure?
Staff costs have skyrocketed to unprecedented levels.
Q&M Dental Group floors the gas pedal on growth in Singapore
The city-state is the firm’s core market.
Here’s why Riverstone Holdings is well positioned to withstand demand headwinds
It’ll be boosted by favorable forex movement.
Open season for pharma firms as Vietnam launches public immunisation programme
The programmes will remove a major roadblock for pharmaceutical firms.
Consumers and doctors disagree regarding access to electronic health records, says survey
82% of consumers in Singapore want full access.
Is Singapore's medical tourism sector losing its lustre?
Modernisation at ASEAN hospitals is a key threat.
Telecare will shape pharmaceutical opportunities in the Asia-Pacific region: BMI
Singapore and Hong Kong will benefit the most, they said.
MSD and the journey to address cancer
MSD, also known as Merck in the US and Canada, is celebrating 125 sterling years of saving lives through breakthroughs, innovative drugs, and therapies.
Read Here
Advertise
Sign Up
Commentary
Strategic brand & design: A smart prescription to drive growth in healthcare